Skip to content

Venous Thromboembolism Taskforce Audit Program

Venous Thromboembolism Taskforce Audit Program

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00535171
Enrollment
8764
Registered
2007-09-26
Start date
2007-06-30
Completion date
Unknown
Last updated
2010-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thrombosis

Brief summary

To determine the effect of an interventional campaign run by a dedicated VTE Nurse Educator over a 6-month period and the effect on prophylaxis rates. To determine the proportion of medically admitted patients with risk factors for VTE. To assess and compare the use of venous thromboembolism (VTE) prophylaxis in hospitalized medical patients versus recommendations and current guidelines. To determine the patient characteristics of those deemed to be at risk of VTE. To determine the proportion of patients receiving appropriate thromboprophylaxis for their risk. To determine the type and duration (where possible) of prophylaxis used.

Interventions

None listed

Sponsors

Sanofi
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hospital admission for an acute illness with an in-patient hospital stay of 3 days or more.

Exclusion criteria

* Patients who have undergone any type of surgery during current admission * Patients who are admitted to a ward or department that is excluded from this study e.g psychiatric, paediatric, maternity, intensive care unit, coronary care unit. * Prior enrollment in this protocol during current admission * Prior enrollment in a VTE study involving pharmaceutical or mechanical treatment within last 90 days. * Admission for suspected or diagnosed deep vein thrombosis The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026